[HTML][HTML] Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
P Bossi, C Resteghini, N Paielli, L Licitra, S Pilotti… - Oncotarget, 2016 - ncbi.nlm.nih.gov
EGFR is an extensively studied biomarker in head and neck squamous cell carcinoma
(HNSCC). In this review, we discuss the prognostic and predictive role of EGFR in HNSCC …
(HNSCC). In this review, we discuss the prognostic and predictive role of EGFR in HNSCC …
EGFR Mutations in Head and Neck Squamous Cell Carcinoma
S Nair, JA Bonner, M Bredel - International Journal of Molecular Sciences, 2022 - mdpi.com
EGFR is a prototypical receptor tyrosine kinase that is overexpressed in multiple cancers
including head and neck squamous cell carcinoma (HNSCC). The standard of care for …
including head and neck squamous cell carcinoma (HNSCC). The standard of care for …
Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication
JV Bagan, C Scully - Oral oncology, 2008 - Elsevier
This paper provides a synopsis of the main papers on epidemiology, diagnosis and
prognosis of oral and oropharyngeal squamous cell carcinoma (OSCC) and head and neck …
prognosis of oral and oropharyngeal squamous cell carcinoma (OSCC) and head and neck …
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
ME Sharafinski, RL Ferris, S Ferrone… - Head & neck, 2010 - Wiley Online Library
Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR)
as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC) …
as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC) …
MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer
Background miR-18a is one of the most up-regulated miRNAs in colorectal cancers (CRC)
based on miRNA profiling. In this study, we examined the functional significance of miR-18a …
based on miRNA profiling. In this study, we examined the functional significance of miR-18a …
[HTML][HTML] The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas
J Martinez-Useros, J Garcia-Foncillas - Oral oncology, 2015 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) represent 95% of head and neck cancer
with an incidence of over half a million people globally. The prognosis for patients with …
with an incidence of over half a million people globally. The prognosis for patients with …
Genome-wide loss of heterozygosity and DNA copy number aberration in HPV-negative oral squamous cell carcinoma and their associations with disease-specific …
C Chen, Y Zhang, MM Loomis, MP Upton… - PloS one, 2015 - journals.plos.org
Oral squamous cell cancer of the oral cavity and oropharynx (OSCC) is associated with high
case-fatality. For reasons that are largely unknown, patients with the same clinical and …
case-fatality. For reasons that are largely unknown, patients with the same clinical and …
[HTML][HTML] Role of EGFR gene polymorphisms in oral squamous cell carcinoma patients of Southeast Iran: A case-control study
S Saravani, N Parsamanesh… - Caspian Journal of …, 2020 - ncbi.nlm.nih.gov
Background: The decisive etiology of oral squamous cell carcinoma (OSCC) is still
ambiguous, but we recognize the contribution of genetic aberration and environmental …
ambiguous, but we recognize the contribution of genetic aberration and environmental …
Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer
S Kim, JR Grandis, A Rinaldo… - Head & Neck: Journal …, 2008 - Wiley Online Library
The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic
target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been …
target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been …
Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma
EGFR polymorphisms have not been thoroughly evaluated for association with head and
neck squamous cell carcinoma (HNSCC) risk. We genotyped 578 HNSCC patients and 588 …
neck squamous cell carcinoma (HNSCC) risk. We genotyped 578 HNSCC patients and 588 …